Back to Search
DAVID BILHARTZ, MD
MD
Urology Physician
NPI: 1952380875Individual
Specialties, Licenses & Credentials
Research & Publications (2)
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.
PMID 16286123·Urology·2005
3-trial
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
PMID 15860850·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2801 CHARLOTTE AVE
NASHVILLE, TN 37209 - Phone
- (615) 250-9200
Quick Facts
- NPI
- 1952380875
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 2
Are you this provider?
Claim Your Profile